Related Experiment Video

Updated: Aug 8, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

Oncolytic viruses and cancer treatment

H Španielová, R Brdička

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |March 3, 2023
    PubMed
    Abstract

    Insights

    Oncolytic viruses are engineered to target and destroy cancer cells, reviving the immune system to fight tumors. This review explores strategies to enhance their specificity and efficacy in cancer therapy.

    Area of Science:

    • Oncology
    • Virology
    • Immunotherapy

    Background:

    • Tumor growth is characterized by a unique microenvironment that suppresses immune responses.
    • Oncolytic viruses exploit this microenvironment, triggering anti-tumor immunity and cancer cell death.
    • Oncolytic viruses are promising as adjuvant immunomodulatory cancer treatments.

    Approach:

    • This review discusses optimization strategies for oncolytic virus specificity and efficacy.
    • It examines methods to ensure viruses replicate exclusively in tumor cells, sparing normal tissues.
    • The review presents key findings from preclinical and clinical investigations.

    Key Points:

    • Specificity is crucial for oncolytic virus therapy to prevent off-target effects.
    • Enhancing viral replication in tumor cells increases therapeutic potential.
    • Combining oncolytic viruses with other treatments may improve outcomes.

    Conclusions:

    • Oncolytic virus development focuses on improving cancer specificity and treatment efficacy.
    • Ongoing research and clinical trials are vital for advancing this therapeutic approach.
    • Oncolytic viruses represent a significant advancement in biological cancer treatment.
    Keywords:
    immunotherapyimmunother­apymolecular targeted therapyneoplasmsoncolytic virotherapytumor microenvironmenttumors

    More Related Videos

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

    Published on: April 3, 2018

    9.1K
    Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

    Ex Vivo Infection of Live Tissue with Oncolytic Viruses

    Published on: June 25, 2011

    12.7K

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    7.9K
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    611
    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    468
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    5.3K
    Mechanisms of Retrovirus-induced Cancers01:51

    Mechanisms of Retrovirus-induced Cancers

    Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
    5.2K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K